Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

K. D. Cummins; S. M. Jane; S. Nikovic; Ali Bazargan; Robin J A Filshie; G Sutrave; Mark Hertzberg; A. Scott; S. Lane; C. K. Yannakou; Peter D. Ritchie; J. D'Rozario; J. Black; Ketan Bavishi; A. Wei

doi:10.1038/bcj.2014.59

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

K. D. Cummins, S. M. Jane, S. Nikovic, Ali Bazargan, Robin J A Filshie, G Sutrave, Mark Hertzberg, A. Scott, S. Lane, C. K. Yannakou, Peter D. Ritchie, J. D'Rozario, J. Black, Ketan Bavishi, A. Wei

Research output: Contribution to journal › Letter › Other › peer-review

4 Citations (Scopus)

Original language	English
Article number	e237
Journal	Blood Cancer Journal
Volume	4
Issue number	8
DOIs	https://doi.org/10.1038/bcj.2014.59
Publication status	Published - 2014

Access to Document

10.1038/bcj.2014.59

39855122Final published version, 132 KB

Cite this

Cummins, K. D., Jane, S. M., Nikovic, S., Bazargan, A., Filshie, R. J. A., Sutrave, G., Hertzberg, M., Scott, A., Lane, S., Yannakou, C. K., Ritchie, P. D., D'Rozario, J., Black, J., Bavishi, K., & Wei, A. (2014). Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia. Blood Cancer Journal, 4(8), Article e237. https://doi.org/10.1038/bcj.2014.59

@article{9135a560de9b4d65abb3367a13762bdf,

title = "Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia",

author = "Cummins, {K. D.} and Jane, {S. M.} and S. Nikovic and Ali Bazargan and Filshie, {Robin J A} and G Sutrave and Mark Hertzberg and A. Scott and S. Lane and Yannakou, {C. K.} and Ritchie, {Peter D.} and J. D'Rozario and J. Black and Ketan Bavishi and A. Wei",

year = "2014",

doi = "10.1038/bcj.2014.59",

language = "English",

volume = "4",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "8",

}

Cummins, KD, Jane, SM, Nikovic, S, Bazargan, A, Filshie, RJA, Sutrave, G, Hertzberg, M, Scott, A, Lane, S, Yannakou, CK, Ritchie, PD, D'Rozario, J, Black, J, Bavishi, K & Wei, A 2014, 'Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia', Blood Cancer Journal, vol. 4, no. 8, e237. https://doi.org/10.1038/bcj.2014.59

TY - JOUR

T1 - Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

AU - Cummins, K. D.

AU - Jane, S. M.

AU - Nikovic, S.

AU - Bazargan, Ali

AU - Filshie, Robin J A

AU - Sutrave, G

AU - Hertzberg, Mark

AU - Scott, A.

AU - Lane, S.

AU - Yannakou, C. K.

AU - Ritchie, Peter D.

AU - D'Rozario, J.

AU - Black, J.

AU - Bavishi, Ketan

AU - Wei, A.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84906854162&partnerID=8YFLogxK

U2 - 10.1038/bcj.2014.59

DO - 10.1038/bcj.2014.59

M3 - Letter

C2 - 25105536

AN - SCOPUS:84906854162

SN - 2044-5385

VL - 4

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 8

M1 - e237

ER -

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

Access to Document

Other files and links

Cite this